Association Between -308G/A TNFA Polymorphism and Susceptibility to Type 2 Diabetes Mellitus: A Systematic Review

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2016 Nov 9

PMID 27822481

Citations 5

Authors

Geisa Izetti Luna

Izabel Cristina Rodrigues da Silva

Mauro Niskier Sanchez

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus (DM) is considered to be a worldwide epidemic disease and its type 2 form comprises more than 95% of all cases. Tumor necrosis factor-alpha (TNF-) is a proinflammatory cytokine. Its dysregulation has been implicated in a variety of human diseases, including type 2 diabetes mellitus (T2DM). The control of expression of this cytokine is associated with insulin resistance and has a strong genetic influence. In order to understand this relationship, the literature from all case-control studies since 2000 to date was reviewed. The genotypes frequency results presented in ten publications with different ethnicities were compared. The correlation between the TNFA promoter genotypes and the risk of developing T2DM remains controversial due to the many discrepancies between the different studies available. Ethnic differences may play a role in these conflicting results, since the distribution of TNFA promoter polymorphisms is distinctive between individuals of dissimilar racial origin. Hence, although the relationship between T2DM incidence and presence of polymorphisms at position -308 of the TNFA gene is not entirely clear, the results of these studies suggest the need for further investigation.

Citing Articles

Comparative analysis of TNF-α (-308) gene polymorphism in Turkish patients with type 2 diabetes developing nephropathy and/or neuropathy.

Can V, Gunay O, Cesur S Sci Rep. 2024; 14(1):31731.

PMID: 39738562 PMC: 11686196. DOI: 10.1038/s41598-024-82773-1.

Association of -α 308G/A and Gln223Arg Polymorphisms with the Risk of Type 2 Diabetes Mellitus.

Trapali M, Houhoula D, Batrinou A, Kanellou A, Strati I, Siatelis A Genes (Basel). 2022; 13(1).

PMID: 35052401 PMC: 8796026. DOI: 10.3390/genes13010059.

Association of IL-10 (- 1082 A/G) and IL-6 (- 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population.

Ayelign B, Negash M, Andualem H, Wondemagegn T, Kassa E, Shibabaw T BMC Endocr Disord. 2021; 21(1):70.

PMID: 33858419 PMC: 8051082. DOI: 10.1186/s12902-021-00738-1.

The Gene Polymorphisms (-308G/A) and the Tumor Necrosis Factor-alpha Levels in Type 2 Diabetic Patients with and Without Tuberculosis Infection.

Daulay M, Sari M, Wahyuni D, Syarifah S Open Access Maced J Med Sci. 2020; 7(23):3960-3964.

PMID: 32165936 PMC: 7061401. DOI: 10.3889/oamjms.2019.824.

TNF-α (-308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients.

Ayelign B, Genetu M, Wondmagegn T, Adane G, Negash M, Berhane N Diabetes Metab Syndr Obes. 2019; 12:2453-2459.

PMID: 31819571 PMC: 6886533. DOI: 10.2147/DMSO.S229987.

References

Abraham L, Kroeger K . Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999; 66(4):562-6. DOI: 10.1002/jlb.66.4.562. View

Esser N, Legrand-Poels S, Piette J, Scheen A, Paquot N . Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014; 105(2):141-50. DOI: 10.1016/j.diabres.2014.04.006. View

Wilson A, Symons J, McDowell T, McDevitt H, Duff G . Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997; 94(7):3195-9. PMC: 20345. DOI: 10.1073/pnas.94.7.3195. View

Garg P, Saraswathy K, Kumar Kalla A, Sinha E, Ghosh P . Pro-inflammatory cytokine gene polymorphisms and threat for coronary heart disease in a North Indian Agrawal population. Gene. 2012; 514(1):69-74. DOI: 10.1016/j.gene.2012.10.011. View

Lee I, Shiroma E, Lobelo F, Puska P, Blair S, Katzmarzyk P . Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012; 380(9838):219-29. PMC: 3645500. DOI: 10.1016/S0140-6736(12)61031-9. View

Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong M . Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J. 2012; 13(6):514-22. DOI: 10.1038/tpj.2012.43. View

Mohlke K, Boehnke M . Recent advances in understanding the genetic architecture of type 2 diabetes. Hum Mol Genet. 2015; 24(R1):R85-92. PMC: 4572004. DOI: 10.1093/hmg/ddv264. View

Ban H, Heo J, Oh K, Park K . Identification of type 2 diabetes-associated combination of SNPs using support vector machine. BMC Genet. 2010; 11:26. PMC: 2875201. DOI: 10.1186/1471-2156-11-26. View

Dabhi B, Mistry K . Oxidative stress and its association with TNF-α-308 G/C and IL-1α-889 C/T gene polymorphisms in patients with diabetes and diabetic nephropathy. Gene. 2015; 562(2):197-202. DOI: 10.1016/j.gene.2015.02.069. View

10.

Murea M, Ma L, Freedman B . Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012; 9(1):6-22. PMC: 3448170. DOI: 10.1900/RDS.2012.9.6. View

11.

Bouhaha R, Baroudi T, Ennafaa H, Vaillant E, Abid H, Sassi R . Study of TNFalpha -308G/A and IL6 -174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem. 2010; 43(6):549-52. DOI: 10.1016/j.clinbiochem.2010.01.008. View

12.

Sefri H, Benrahma H, Charoute H, Lakbakbi El Yaagoubi F, Rouba H, Lyoussi B . TNF A -308G>A polymorphism in Moroccan patients with type 2 diabetes mellitus: a case-control study and meta-analysis. Mol Biol Rep. 2014; 41(9):5805-11. DOI: 10.1007/s11033-014-3454-5. View

13.

Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J . Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992; 35(11):1060-7. DOI: 10.1007/BF02221682. View

14.

Evert A, Boucher J, Cypress M, Dunbar S, Franz M, Mayer-Davis E . Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013; 37 Suppl 1:S120-43. DOI: 10.2337/dc14-S120. View

15.

Saxena M, Srivastava N, Banerjee M . Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus. Mol Biol Rep. 2013; 40(11):6271-9. DOI: 10.1007/s11033-013-2739-4. View

16.

Jin W, Patti M . Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin Sci (Lond). 2008; 116(2):99-111. DOI: 10.1042/CS20080090. View

17.

Koch F, Kammerer P, Kammerer P, Al-Nawas B, Brieger J . Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma. Oral Oncol. 2010; 46(2):128-33. DOI: 10.1016/j.oraloncology.2009.11.014. View

18.

Wang X, Strizich G, Hu Y, Wang T, Kaplan R, Qi Q . Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction. J Diabetes. 2015; 8(1):24-35. DOI: 10.1111/1753-0407.12323. View

19.

Prisco A, Hoffmann B, Kaczorowski C, McDermott-Roe C, Stodola T, Exner E . Tumor Necrosis Factor α Regulates Endothelial Progenitor Cell Migration via CADM1 and NF-kB. Stem Cells. 2016; 34(7):1922-33. PMC: 4931961. DOI: 10.1002/stem.2339. View

20.

Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A . Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Ren Fail. 2004; 26(6):633-9. DOI: 10.1081/jdi-200037165. View